J W Raschko
Overview
Explore the profile of J W Raschko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shibata S, Pezner R, Chu D, Doroshow J, Chow W, Leong L, et al.
Eur J Surg Oncol
. 2004 Jul;
30(6):650-7.
PMID: 15256240
Aim: We describe the feasibility of combining infusional 5-fluorouracil (5-FU) with intraoperative radiation therapy (IORT). Methods: Patients with surgically resectable locally advanced gastrointestinal cancers were treated concurrently during surgery with...
2.
Somlo G, Doroshow J, Synold T, Longmate J, Reardon D, Chow W, et al.
Br J Cancer
. 2001 Jun;
84(12):1591-8.
PMID: 11401310
We assessed the feasibility and pharmacokinetics of high-dose infusional paclitaxel in combination with doxorubicin, cyclophosphamide, and peripheral blood progenitor cell rescue. Between October 1995 and June 1998, 63 patients with...
3.
Raschko J, Synold T, Chow W, Coluzzi P, Hamasaki V, Leong L, et al.
Cancer Chemother Pharmacol
. 2000 Dec;
46(5):403-10.
PMID: 11127945
Purpose: In recognition of the variety of available chemotherapeutic modulating agents and their potential to enhance the efficacy of platinum-based therapy, we embarked upon a phase I study to investigate...
4.
Tetef M, Margolin K, Doroshow J, Akman S, Leong L, Morgan Jr R, et al.
Cancer Chemother Pharmacol
. 2000 Jul;
46(1):19-26.
PMID: 10912573
Purpose: To evaluate the pharmacokinetics and toxicity of high-dose intravenous (i.v.) methotrexate (MTX) with leucovorin in patients with meningeal carcinomatosis. Methods: Of 16 eligible patients entered on this study, 13...
5.
Portenoy R, Payne R, Coluzzi P, Raschko J, Lyss A, Busch M, et al.
Pain
. 1999 Mar;
79(2-3):303-12.
PMID: 10068176
Oral transmucosal fentanyl citrate (OTFC) is a novel opioid formulation in which the potent synthetic mu-agonist fentanyl is embedded in a sweetened matrix that is dissolved in the mouth. It...
6.
Newman E, Carroll M, Akman S, Chow W, Coluzzi P, Hamasaki V, et al.
Cancer Chemother Pharmacol
. 1997 Jan;
39(3):254-8.
PMID: 8996529
A group of 18 patients with advanced cancer were entered on a phase I study of a 120-h continuous intravenous infusion of hydroxyurea. The dose of hydroxyurea was escalated in...
7.
Somlo G, Doroshow J, Ahn D, Hwang L, Raschko J, Forman S, et al.
J Clin Oncol
. 1995 May;
13(5):1231-7.
PMID: 7738626
Purpose: To evaluate the protective effect of low-dose dopamine given as continuous infusion in patients who undergo chemotherapy with the nephrotoxin cisplatin. Patients And Methods: Forty-two patients who received high-dose...
8.
Margolin K, Akman S, Leong L, Morgan R, Somlo G, Raschko J, et al.
Cancer Chemother Pharmacol
. 1995 Jan;
36(4):293-8.
PMID: 7628048
A phase I study of mitomycin C with menadione (2-methyl-1,4-naphthoquinone, a vitamin K analogue which lowers intracellular pools of reduced glutathione) was designed as an approach to overcoming tumor cell...
9.
Margolin K, Green S, Osborne K, Doroshow J, Akman S, Leong L, et al.
Am J Clin Oncol
. 1994 Apr;
17(2):175-80.
PMID: 8141112
The use of leucovorin to modulate 5-fluorouracil (FUra)-mediated inhibition of thymidylate synthase has been shown both in vitro and in vivo to improve the antitumor activity of FUra. Based on...
10.
Somlo G, Doroshow J, Forman S, Leong L, Margolin K, Morgan Jr R, et al.
Cancer
. 1994 Mar;
73(6):1678-85.
PMID: 7512436
Background: Chemotherapy with a doxorubicin-containing regimen results in high overall response rates in the treatment of metastatic adenocarcinoma of the breast; the combination of doxorubicin, etoposide, and cyclophosphamide has produced...